Recent Finacing
Recent Raise
ShiraTronics develops and clinically tests a neurostimulation device for chronic migraine, holds FDA Breakthrough Device designation and is conducting the randomized, sham-controlled RELIEV-CM2 pivotal trial.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at ShiraTronics.
